GSE221386 romidepsin 2 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE221386_romidepsin_2_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE221386_romidepsin_2_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE221386_romidepsin_2_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE221386_romidepsin_2_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

SRC kinase signaling inhibitor 1

Gene

lung cancer associated transcript 1

Gene

H3 clustered histone 10

Gene

HERPUD2 antisense RNA 1

Gene

long intergenic non-protein coding RNA 632

Gene

RNA component of 7SK nuclear ribonucleoprotein

Gene

RNA polymerase II subunit J4 (pseudogene)

Gene

IGFL2 antisense RNA 1

Gene

fatty acyl-CoA reductase 2 pseudogene 1

Gene

MIR9-3 host gene

  • Gene

    SRC kinase signaling inhibitor 1


  • Gene

    lung cancer associated transcript 1


  • Gene

    H3 clustered histone 10


  • Gene

    HERPUD2 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    RNA component of 7SK nuclear ribonucleoprotein


  • Gene

    RNA polymerase II subunit J4 (pseudogene)


  • Gene

    IGFL2 antisense RNA 1


  • Gene

    fatty acyl-CoA reductase 2 pseudogene 1


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.